Melvin H. Freedman
Research Subjects
Research Interests
Melvin H. Freedman has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Yigal Dror
Genetics and Genome Biology Program The Hospital for Sick Children Toronto Ontario Canada
4 shared publications Alen Bernstein
Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Canada
1 shared publicationAnnette Poon
Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Canada
1 shared publicationElaine W. Leung
Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, the Hospital for Sick Children and the University of Toronto, 555 University Avenue, Toronto, Ontario, Canada
1 shared publicationGeorgina Caruana
Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Canada
1 shared publicationIan Thornley
Division of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, Ontario, Canada
1 shared publication
Latest Publications
- 1 June 2006
- Published by Wiley in British Journal of Haematology
- Vol. 133 (5) , 558-561
Shwachman-Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis
Bone marrow angiogenesis is increased in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), but has not been studied in inherited or acquired marrow failure syndromes. Shwachman-Diamond syndrome (SDS) carries a high risk of MDS/AML and is characterised by marrow stromal dysfunction. Compared with controls, SDS patients without MDS/AML had higher marrow microvessel density. Stromal VEGF gene expression, stromal vascular endothelial growth factor (VEGF) secretion and VEGF levels in serum and marrow mononuclear cells were normal. Future studies should investigate the mechanism for increased angiogenesis in SDS, and whether SDS marrow, with its increased angiogenesis, promotes progression of malignant clones.
- 1 June 2006
- Published by Wiley in British Journal of Haematology
- Vol. 133 (5) , 558-561
Shwachman-Diamond syndrome: an inherited model of aplastic anaemia with accelerated angiogenesis
Bone marrow angiogenesis is increased in myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), but has not been studied in inherited or acquired marrow failure syndromes. Shwachman-Diamond syndrome (SDS) carries a high risk of MDS/AML and is characterised by marrow stromal dysfunction. Compared with controls, SDS patients without MDS/AML had higher marrow microvessel density. Stromal VEGF gene expression, stromal vascular endothelial growth factor (VEGF) secretion and VEGF levels in serum and marrow mononuclear cells were normal. Future studies should investigate the mechanism for increased angiogenesis in SDS, and whether SDS marrow, with its increased angiogenesis, promotes progression of malignant clones.
- Open Access
- 25 March 2002
- Published by Wiley in British Journal of Haematology
- Vol. 117 (1) , 189-192
Abnormal telomere shortening in leucocytes of children with Shwachman–Diamond syndrome
Summary. Haemopoietic dysfunction, ranging from single‐lineage cytopenia to severe aplasia and/or myelodysplasia (MDS), is prominent in Shwachman–Diamond syndrome (SDS). To assess haemopoietic stem cell proliferation in SDS, we compared leucocyte telomere length in 12 patients with SDS to that of 41 controls, using an in‐gel hybridization technique. SDS patients had an age‐adjusted mean telomere length 1·4 kilobase pairs (kbp) shorter than controls (P < 0·0001). Patients with'non‐severe′ SDS (one‐ or two‐lineage cytopenias; no MDS) had shortened telomeres (−1·4 kbp; P = 0·0004), as did those with ‘severe’ SDS. We conclude that stem cell hyperproliferation is a feature of SDS from its outset.
- 25 March 2002
- Published by Wiley in British Journal of Haematology
- Vol. 117 (1) , 189-192
Open AccessAbnormal telomere shortening in leucocytes of children with Shwachman–Diamond syndrome
Summary. Haemopoietic dysfunction, ranging from single‐lineage cytopenia to severe aplasia and/or myelodysplasia (MDS), is prominent in Shwachman–Diamond syndrome (SDS). To assess haemopoietic stem cell proliferation in SDS, we compared leucocyte telomere length in 12 patients with SDS to that of 41 controls, using an in‐gel hybridization technique. SDS patients had an age‐adjusted mean telomere length 1·4 kilobase pairs (kbp) shorter than controls (P < 0·0001). Patients with'non‐severe′ SDS (one‐ or two‐lineage cytopenias; no MDS) had shortened telomeres (−1·4 kbp; P = 0·0004), as did those with ‘severe’ SDS. We conclude that stem cell hyperproliferation is a feature of SDS from its outset.
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 149A
Practical Classification of Pediatric Myelodysplasia (CCC System)
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 149A
Practical Classification of Pediatric Myelodysplasia (CCC System)
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 146A
Mastocytosis Cells Bearing the c-kit Activating Point Mutation Are Characterized by Hypersensitivity to Stem Cell Factor (SCF) and Increased Apoptosis
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 146A
Mastocytosis Cells Bearing the c-kit Activating Point Mutation Are Characterized by Hypersensitivity to Stem Cell Factor (SCF) and Increased Apoptosis
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 145A
Marrow Cells from Patients with Shwachman-Diamond Syndrome (SDS) are Characterized by Markedly Increased Apoptosis
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 145A
Marrow Cells from Patients with Shwachman-Diamond Syndrome (SDS) are Characterized by Markedly Increased Apoptosis